Publication: 2649

NCCTG N0879 (Alliance): A randomized phase 2 cooperative group trial of carboplatin, paclitaxel, and bevacizumab ± everolimus for metastatic melanoma.
      QxMD      Google Scholar   
Citation:
Cancer vol 124 (3) 537-45
Year:
2018
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
7
Parents:
2275  
Children:
None
Program:
OGC
Primary Committee:
Experimental
Sec. Committees:
   
Pharmas:
Novartis, Genentech/Roche  
Grants:
U10CA180821, U10CA180882, CA025224, U10CA180790, UG1CA189825, UG1CA189863, U10 CA180821, U10 CA180882  
Corr. Author:
 
Authors:
                           
Networks:
IL043, LAPS-MN026, METROMIN, ND010   
Study
NCCTG-N0879
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords:
chemotherapy, everolimus, melanoma, uveal